Salix Pharma (SLXP) Misses Q3 EPS by 3c; Issues Weak Q4 Outlook

Go back to Salix Pharma (SLXP) Misses Q3 EPS by 3c; Issues Weak Q4 Outlook

Form 8-K SALIX PHARMACEUTICALS For: Nov 06

November 6, 2014 4:18 PM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More